2-219004022-G-T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_194302.4(CFAP65):c.5485C>A(p.Gln1829Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000136 in 1,614,040 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Consequence
NM_194302.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFAP65 | NM_194302.4 | c.5485C>A | p.Gln1829Lys | missense_variant | 33/35 | ENST00000341552.10 | NP_919278.2 | |
LOC100129175 | NR_046086.1 | n.86+1722G>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFAP65 | ENST00000341552.10 | c.5485C>A | p.Gln1829Lys | missense_variant | 33/35 | 5 | NM_194302.4 | ENSP00000340776 | A2 | |
ENST00000441450.1 | n.86+1722G>T | intron_variant, non_coding_transcript_variant | 2 | |||||||
CFAP65 | ENST00000453220.5 | c.5485C>A | p.Gln1829Lys | missense_variant | 31/33 | 5 | ENSP00000409117 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152134Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251306Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135812
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461788Hom.: 0 Cov.: 32 AF XY: 0.0000206 AC XY: 15AN XY: 727184
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152252Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74420
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The CFAP65 p.Q1829K variant was not identified in the literature nor was it identified in Clinvar. The variant was identified in dbSNP (ID: rs535436534) and in control databases in 6 of 251306 chromosomes at a frequency of 0.00002388 (Genome Aggregation Database March 6, 2019, v2.1.1). The p.Q1829 residue is conserved in mammals and computational analyses (MUT Assesor, PolyPhen-2, SIFT, MutationTaster, Revel, FATHMM, MetaLR, DANN) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (Splice AI exome) do not predict a deleterious effect on splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at